用於治療青光眼的LINGO-1拮抗劑和TRKB受體激動劑
- 专利权人:
- BIOGEN MA INC.
- 发明人:
- MI, SHA
- 申请号：
- HK10109474.4
- 公开号：
- HK1142777B
- 申请日:
- 2010.10.05
- 申请国别(地区):
- HK
- 年份:
- 2015
- 代理人:
- 摘要：
- This invention relates to methods for promoting neuronal survival and regeneration using LINGO-1 antagonists and TrkB agonists. Additionally, the invention relates to methods for treating pressure induced optic neuropathies using LINGO-1 antagonists. The invention also relates generally to methods for increasing TrkB activity and inhibiting JNK pathway signaling using a LINGO-1 antagonist.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ANTAGONISTES LINGO-1 ET AGONISTES TRKB POR LEUR UTILISATION DANS LE TRAITEMENT DU GLAUCOME
- Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell, survival via administration of lingo-1 antagonists and TrkB agonists
- Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of Lingo-1 Antagonists and TrkB Agonists
- METHOD FOR TREATING PRESSURE INDUCED OPTIC NEUROPATHY, PREVENTING NEURONAL DEGENERATION AND PROMOTING NEURONAL CELL SURVIVAL VIA ADMINISTRATION OF LINGO-1 ANTAGONIST AND TrkB AGONIST
- METHODS AND COMPOSITIONS FOR TREATING PATHOLOGIES ASSOCIATED WITH BDNF SIGNALING
